The UK government launches a national security probe into major pharmaceutical investments by US-based Pfizer and Denmark's Novo Nordisk, raising concerns about foreign influence in Britain's vital healthcare sector.
Patients across the UK prescribed Prazosin for blood pressure or prostate issues face urgent medication recall after FDA discovers dangerous carcinogens in tablets. Multiple manufacturers affected.
Exclusive investigation reveals Donald Trump's relentless pressure on FDA officials to fast-track leucovorin for autism treatment despite limited scientific evidence and expert warnings.
A critical safety alert has been issued for specific batches of Prazosin Hydrochloride tablets after potential contamination was discovered. Patients advised to check their medication immediately.
Celebrating the extraordinary life of pharmacist Alan Kilburn, whose pioneering work revolutionised medicine dispensing and championed patient care across the UK.
Danish pharmaceutical giant Novo Nordisk enters bidding war with Pfizer for obesity biotech firm Metsera, signalling major shift in weight-loss treatment market competition.
Ireland's Department of Finance confronts a staggering €13.4bn corporate tax shortfall as tech and pharmaceutical giants see profits decline, threatening the nation's economic stability.
A bitter pricing dispute between the UK government and pharmaceutical companies threatens to delay vital new medicines for NHS patients, with industry leaders warning of an escalating crisis.
Tributes pour in for pioneering pharmacist Robert Wilkinson, whose groundbreaking work revolutionised NHS patient care and established new standards for community pharmacy across Britain.
Emma Walmsley warns that proposed NHS drug pricing reforms could devastate Britain's pharmaceutical industry and drive investment overseas in stark government warning.
Pharmaceutical giant GSK faces significant market pressure as its experimental HIV prevention drug shows mixed results in clinical trials, sending shares tumbling nearly 10%.
Britain faces a stark economic reckoning as official forecasts slash productivity growth, triggering speculation about imminent tax rises while major corporations voice concerns over investment climate.
Urgent medication safety warning as cholesterol drug Atorvastatin faces massive recall over contamination fears. FDA investigation reveals critical manufacturing issues.
A pioneering new treatment has demonstrated remarkable success in slowing memory loss and cognitive decline in Alzheimer's patients, offering fresh hope for millions affected by the devastating condition.
Exclusive investigation reveals how NHS patients across Britain are being denied essential medicines due to catastrophic supply chain failures, with government accused of prioritising pharmaceutical profits over public health.
Danish pharmaceutical giant Novo Nordisk faces major leadership shakeup as chairman and six board members step down following unprecedented growth of weight-loss drug Wegovy.
In a landmark development for UK life sciences, Moderna's cutting-edge mRNA vaccine research centre is coming to Oxfordshire, creating hundreds of jobs and cementing Britain's position in global healthcare innovation.
Rishi Sunak launches blistering attack on Scotland's First Minister John Swinney over alleged covert independence plan, accusing him of treating Scottish voters 'with contempt' in explosive Westminster clash.
Former President Donald Trump's critical comments about weight-loss drugs like Ozempic triggered dramatic market movements, wiping billions from pharmaceutical giants before a partial recovery.
Former President Donald Trump pledges to slash prices of weight-loss drugs Ozempic and Wegovy, sending pharmaceutical stocks tumbling and sparking healthcare debate.
Governor Gavin Newsom takes unprecedented action against pharmaceutical giants as insulin prices soar, making California first US state to produce its own affordable medication.
In a significant political victory, Donald Trump secures FDA approval for Washington's IVF medication, overcoming fierce opposition and setting new healthcare precedents.
Breakthrough drug Retatrutide demonstrates remarkable 24% weight loss in clinical trials, potentially revolutionising obesity treatment in the UK healthcare landscape.
Pharmaceutical giant Johnson & Johnson agrees to pay $700 million settlement amid allegations their talcum powder contained asbestos and caused ovarian cancer in thousands of women.
Global pharmaceutical giant Johnson & Johnson is confronting a major class action lawsuit in the UK, with dozens of women alleging its talc-based products caused their cancers. The legal battle could set a crucial precedent for consumer safety.
Pharmaceutical giant Johnson & Johnson agrees to pay £50 billion to settle claims its talcum powder caused cancer, while continuing to deny product safety concerns.
Exclusive analysis reveals the Scottish Government's independence plan is in disarray, with even First Minister John Swinney appearing directionless on the path to Indyref2 amid growing internal confusion.
The World Health Organization issues urgent global warning after contaminated cough syrups are connected to dozens of child fatalities across several nations. Health authorities worldwide are scrambling to remove dangerous medications from circulation.
In a landmark pharmaceutical reversal, the opium-based pain medication Opium is set to be reintroduced in England and Wales after being withdrawn from the market nearly five decades ago, offering new hope for chronic pain sufferers.
Native American communities face critical shortages of diabetes medications like Ozempic as wealthy New Yorkers exploit prescriptions for weight loss, creating a healthcare crisis for vulnerable populations.